NPPB and type 2 diabetes mellitus: evaluated the predictive performance of NT-proBNP with the recently published ESC/European Association for the Study of Diabetes (EASD) risk stratification model and the Systemic Coronary Risk Evaluation (SCORE) in patients with type 2 diabetes [30].